← Back to news

Markets

TSMC Hitting Production Capacity Limits, Says Broadcom

Y

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Y

Tether Says It Will Be Audited By Big Four Accounting Firm—But Won't Say Which One

Y

Core & Main Q4 Earnings Call Highlights

Y

Smithfield Foods Q4 Earnings Call Highlights

Y

Cadeler A/S H2 Earnings Call Highlights

Y

LENZ Therapeutics Q4 Earnings Call Highlights

Y

Hesai Group Q4 Earnings Call Highlights

Y

Is Smurfit Westrock Stock Underperforming the Dow?

Y

United Airlines Stock Is Rebounding as Oil Prices Fluctuate. Should You Buy the UAL Stock Dip?

Y

Palantir Just Scored a Major Department of Defense Win. Should You Buy PLTR Stock Now?

Y

Lean Hog Prices Are Falling: Sell When They Hit This Price

Y

What OpenAI’s IPO Risk Disclosure Really Tells Us About Microsoft’s Position

Y

Wall Street's Crypto Ties Deepen as NYSE Taps Securitize for Tokenized Securities

Y

From $383 to $500: BofA’s Bold Microsoft Call Rests on Azure and Copilot Momentum

Y

Market Minute 3-24-26- Markets Weigh Mideast Deal Details

Y

Apollo Caps Cashouts at Its $25 Billion Debt Fund. Why Investors Are Rushing for the Exit.

Y

Is F5 Stock Outperforming the Dow?

Y

RadNet (RDNT) Acquires Gleamer for €230 Million

Y

Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target

Y

Waters (WAT) Prices $3.5 Billion Senior Notes Offering

Y

Morgan Stanley Lowers Personalis (PSNL) Price Target to $10

Y

CareDx (CDNA) Launches AI-based Platform VANTx

Y

TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213

Y

Agilent Technologies (A) to Acquire Biocare Medical for $950M

Y

Natera (NTRA) Launches Zenith Genomic Assay

Y

Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial

Y

Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference

Y

Here's How Oil Stock Volatility Is Affecting This Leading Solar Energy Company

Y

Why NexGen Energy’s Rook I Approval Could Mark a Turning Point for Its Uranium Buildout

Y

How Deep Yellow’s Tumas Progress Is Shaping the Next Phase of Its Uranium Development Story

Y

Why HC Wainwright Sees Uranium Energy Well Positioned for a Bigger Production Ramp

Y

How Energy Fuels’ 2026 Outlook Framed 2025 as a Transformational Year for the Company

Y

Why enCore Energy’s 2025 Production Gains Matter for Its Contract-Delivery Strategy

Y

Capital One Has Investors Spooked, but Here’s What Wall Street Expects

Y

Estée Lauder Stock Plunges After Puig Merger Talk. Why It’s Getting Ugly for Shares.

Y

'Buy the Dip' Signal on Uranium Stock Has Never Been Wrong

Y

Why Lenz Therapeutics Stock Crashed Today

Y

Investors Are Betting on an Interest Rate Hike That’s Really Not That Likely

Y

Dollar Supported by Weak Stocks and Higher Bond Yields

Y

Comfort Systems Stock: Is FIX Outperforming the Industrial Sector?

Y

Xcel Energy Could Hit $89 by Year-End as UBS Argues Wildfire Risks Are Already Priced Into $76.75 Stock

Y

3 Dividend Stocks to Buy and Hold Forever

Y

Replenish Nutrients builds a licensing flywheel to scale high-margin fertilizer IP

Y

Foreign Funds Ditch $50 Billion in Asian Stocks as Oil Shock Dims Prospects

Y

Mueller Water Director Buys $739K in Shares — A Bullish Signal for This Water Infrastructure Play?

Y

SanDisk Stock’s Breakout Looks Overdone—Unless the AI Supercycle Is Real

Y

How Oklo’s DOE Milestone Advanced Its Push Into Domestic Isotope Production

Y

Why Ur-Energy’s Higher 2026 Spending Hasn’t Derailed Wall Street’s Broader View

Y

How NuScale Is Expanding Its Nuclear Pitch Beyond Power Generation and Into Industrial Heat

Y